Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs) - Tissot, A; Ambuhl, P; Fulurija, A; Maurer, P; Jennings, G; Nussberger, J; Sabat, R; Volk, H; Wagner, F; Nief, V; Schellekens, C; Sladko, K; et al. (2005)